Patent · US Expired

Compound UCE6

US5366966A · kind A · utility

0Cited by
0References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 4, 1993
Grant dateNov 22, 1994
Priority date—
Expiry dateJun 4, 2013

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C50/38
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A compound represented by formula (I): ##STR1## or a pharmaceutically acceptable salt thereof is provided, which has an excellent antitumor activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.